At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MBOT Microbot Medical Inc
Pre-Market Trading 12-23 05:22:18 EST
0.9745
+0.0010
+0.10%
盘前0.9910
+0.0165+1.69%
05:09 EST
High1.00
Low0.9600
Vol162.12K
Open0.9600
D1 Closing0.9735
Amplitude4.11%
Mkt Cap16.50M
Tradable Cap16.26M
Total Shares16.93M
T/O158.59K
T/O Rate0.97%
Tradable Shares16.69M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
MBOT Stock Gains Following FDA Submission of the LIBERTY System
Microbot Medical Announces the Successful Completion of Its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of Liberty® During 2Q 2025
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
Microbot Medical Accelerates Patient Enrollment of Its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in Its Pivotal Human Clinical Trial for the Liberty Endovascular Robotic Surgical System
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, a disposable robotic system for use in endovascular interventional procedures, such as cardiovascular, peripheral, and neurovascular; NovaCross, an intraluminal revascularization device; ViRob, an autonomous crawling micro-robot that cam crawl in various natural spaces within the human body, including blood vessels, the digestive tract and the respiratory system, as well as artificial spaces such as shunts, catheters, ports, etc.; TipCAT, a disposable self-propelled locomotive device for tubular anatomies; and One & Done platform. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.